Outpatient reimbursement is becoming an increasingly important financial and operational issue for hospitals, physicians, and medical groups as more healthcare services are delivered outside traditional inpatient settings and federal payment policy continues to evolve. Medicare’s proposed 2027 Hospital Outpatient Prospective Payment System rule illustrates how payment rates, site-of-service policies, ambulatory surgical center reimbursement, drug payments, and quality requirements are becoming intertwined with the changing economics of outpatient care.
The Centers for Medicare & Medicaid Services issued its proposed calendar year 2027 Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center rule on July 2, 2026. The proposal would affect approximately 3,500 hospitals and 6,400 ambulatory surgical centers. CMS has proposed a 2.4% payment-rate update for qualifying hospitals and ASCs that meet applicable quality-reporting requirements.
For California physicians, outpatient reimbursement matters even when professional services are billed separately from hospital facility payments. Changes in facility economics can influence where procedures are performed, how health systems structure outpatient services, what resources are available, and how physicians interact with hospitals, medical groups, and ambulatory surgical centers.
Medicare Proposes New Outpatient Reimbursement Rates
Under the proposed 2027 rule, CMS would increase OPPS payment rates by 2.4% for hospitals that satisfy applicable quality-reporting requirements. The proposed increase reflects a projected 3.2% hospital market basket increase reduced by a 0.8-percentage-point productivity adjustment. CMS proposes the same 2.4% update factor for qualifying ambulatory surgical centers.
The proposed percentage increase does not mean that every hospital outpatient service would receive an identical outpatient reimbursement increase. Medicare OPPS payments depend on the classification and payment methodology applicable to individual services, while other policy adjustments can affect particular hospitals, procedures, drugs, or service categories.
This distinction is important for physicians evaluating the financial environment surrounding outpatient care. A headline payment update provides only a broad benchmark. Actual outpatient reimbursement can vary according to procedure mix, service location, applicable ambulatory payment classifications, quality-reporting status, drug policies, and other Medicare payment rules.
CMS’s 2027 proposal remained a proposed rule as of October 8, 2026. The final OPPS/ASC rule will determine the policies and payment rates that take effect for calendar year 2027. The proposed rule itself describes revisions to Medicare’s hospital outpatient and ASC payment systems based on CMS’s continuing experience with those programs.
Site of Service Influences Outpatient Reimbursement
One of the broader questions surrounding outpatient reimbursement is how Medicare pays for comparable services delivered in different healthcare settings. Physicians can provide or participate in care delivered through hospital outpatient departments, physician offices, ambulatory surgical centers, and other outpatient facilities, but payment methodologies are not necessarily identical across those settings.
CMS is simultaneously examining physician payment assumptions connected with site of service. In the proposed 2027 Medicare Physician Fee Schedule, the agency requested comments on whether the existing facility and non-facility site-of-service payment differential remains appropriate and whether alternative approaches should be considered for indirect practice expenses, particularly for physicians employed by hospitals, health systems, or other organizations.
These discussions matter because outpatient reimbursement policy can influence more than the amount paid for a single encounter. Payment structures can affect organizational decisions about where services are delivered, how outpatient facilities are developed, and how physician practices interact financially with hospital systems.
For physicians, the relevant issue is not simply whether one care setting pays more than another. Clinical appropriateness, patient needs, facility capabilities, procedure complexity, staffing, equipment, and safety requirements all influence the appropriate site of service. Payment policy adds another consideration to those clinical and operational decisions.
Hospital and ASC Economics Continue to Converge
The continued development of ambulatory surgical centers has also made outpatient reimbursement increasingly important for procedural specialties. Medicare maintains separate payment systems for hospital outpatient departments and ASCs, creating different financial structures for services that may, when clinically appropriate and permitted under Medicare rules, be performed in more than one outpatient setting.
CMS’s proposed 2.4% update for both OPPS and ASC rates in 2027 reflects the agency’s annual process for adjusting the two systems. However, identical percentage updates do not make the underlying payment systems equivalent. Service eligibility, payment amounts, quality-reporting requirements, facility capabilities, and other rules remain different.
For physicians working across multiple settings, these differences can influence referral and procedural environments. Outpatient reimbursement may affect hospital service-line decisions, ASC participation, scheduling capacity, capital investment, staffing, and whether particular procedures remain financially sustainable in specific locations.
These dynamics are especially relevant as healthcare delivery continues to place substantial emphasis on outpatient treatment. Physicians may increasingly need to understand how facility payment policy interacts with professional reimbursement rather than evaluating the physician fee schedule in isolation.
Drug Payment Changes Add Another Financial Variable
CMS’s proposed 2027 rule also includes a significant change involving drugs acquired through the 340B Drug Pricing Program. CMS reported conducting a hospital acquisition-cost survey between January and April 2026 and identified substantial differences between acquisition costs for 340B drugs and drugs acquired outside the program.
Based on those results, CMS proposes paying for 340B-acquired drugs at average sales price minus 33.4% for 2027. CMS estimates that the proposal would reduce Original Medicare drug payments by approximately $4.55 billion and beneficiary drug payments by approximately $1.15 billion during the first year. Because the policy must be implemented in a budget-neutral manner, CMS proposes increasing OPPS payments for non-drug services by an equivalent amount.
This proposal demonstrates how outpatient reimbursement changes in one category can affect payments elsewhere within the system. Hospital outpatient finance is interconnected, and budget-neutral adjustments can redistribute Medicare payments among different types of services.
For physicians practicing in oncology and other specialties involving significant outpatient drug administration, these policies may be particularly relevant to the financial environment of hospital-based treatment programs. The ultimate effects will depend on the final rule and the circumstances of individual facilities and services.
Quality Reporting Remains Connected to Payment
Medicare’s Hospital Outpatient Quality Reporting Program continues to connect outpatient reimbursement with quality-data submission. Hospital outpatient departments that fail to satisfy applicable reporting requirements receive a two-percentage-point reduction to their annual OPPS payment update. CMS also publishes hospital outpatient quality information through Care Compare.
The ASC Quality Reporting Program uses a similar mechanism. Eligible ambulatory surgical centers that fail to meet program requirements can receive a two-percentage-point reduction to their annual payment-rate update.
For physicians, these programs reinforce the connection between clinical operations, data reporting, facility administration, and outpatient reimbursement. Physicians may not directly control every facility reporting process, but clinical documentation and care delivery can contribute to the information hospitals and ASCs use for quality measurement.
The growing connection between reimbursement and quality reporting means outpatient payment policy cannot be viewed solely as a fee schedule. It increasingly incorporates operational, quality, data, and compliance considerations that can affect healthcare organizations and the physicians practicing within them.
Physicians Face Multiple Payment Systems
A central complication for physicians is that outpatient reimbursement does not operate through a single Medicare payment mechanism. Hospitals receive facility payments under OPPS, ASCs operate under the ASC payment system, and physicians generally receive professional payments under the Medicare Physician Fee Schedule.
CMS issued the proposed 2027 Physician Fee Schedule separately in July 2026, with its own payment and practice-expense changes. This means physicians working in outpatient settings must consider how professional reimbursement interacts with facility-level payment policy.
A procedure performed in a hospital outpatient department can therefore involve different payment streams and economic considerations than the same or similar service performed in another setting. Understanding outpatient reimbursement increasingly requires examining the entire payment environment rather than focusing exclusively on the professional claim.
For California medical groups, this can be particularly important when evaluating hospital affiliations, ambulatory surgery arrangements, service-line expansion, employment agreements, and practice investment. Facility economics can indirectly affect physician operations even when the physician does not receive the facility payment.
Outpatient Reimbursement Will Remain a 2027 Policy Issue
The proposed Medicare changes show why outpatient reimbursement will remain a significant issue as healthcare organizations prepare for 2027. The proposed 2.4% OPPS and ASC updates provide one component of the payment picture, but the broader proposal also addresses drug reimbursement, quality programs, service settings, and other policies affecting outpatient care.
For physicians, the continuing shift toward outpatient care creates both clinical and financial considerations. Medical groups increasingly operate within an environment where professional reimbursement, hospital facility economics, ambulatory surgical center payments, quality requirements, and site-of-service policies interact.
The key distinction is that outpatient reimbursement changes do not affect every physician or healthcare organization in the same way. Effects depend on specialty, practice structure, payer mix, facility relationships, service mix, and the settings in which care is delivered.
As CMS moves from its proposed 2027 rule toward final policy, California physicians and medical groups will have additional information about how Medicare outpatient reimbursement will change. Monitoring those developments can help practices understand not only their own professional payments but also the financial environment surrounding the hospitals and outpatient facilities where their patients receive care.
For the federal proposal and detailed 2027 payment provisions, review the CMS Calendar Year 2027 Hospital Outpatient Prospective Payment System and ASC Proposed Rule fact sheet.
Subscribe to StanfordPhysicianAdvocate.org for continued coverage of California physician policy, Medicare reimbursement, outpatient payment, healthcare regulation, medical practice economics, and emerging developments affecting physicians.